U.S Physical Therapy Operating Expenses 2010-2024 | USPH

U.S Physical Therapy operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
U.S Physical Therapy Annual Operating Expenses
(Millions of US $)
2023 $553
2022 $496
2021 $424
2020 $371
2019 $415
2018 $394
2017 $359
2016 $307
2015 $284
2014 $259
2013 $225
2012 $211
2011 $200
2010 $178
2009 $173
U.S Physical Therapy Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $153
2024-06-30 $148
2024-03-31 $141
2023-12-31 $156
2023-09-30 $134
2023-06-30 $131
2023-03-31 $132
2022-12-31 $134
2022-09-30 $125
2022-06-30 $121
2022-03-31 $117
2021-12-31 $113
2021-09-30 $109
2021-06-30 $105
2021-03-31 $97
2020-12-31 $99
2020-09-30 $89
2020-06-30 $74
2020-03-31 $109
2019-12-31 $107
2019-09-30 $100
2019-06-30 $106
2019-03-31 $101
2018-12-31 $103
2018-09-30 $98
2018-06-30 $98
2018-03-31 $95
2017-12-31 $95
2017-09-30 $90
2017-06-30 $89
2017-03-31 $85
2016-12-31 $80
2016-09-30 $76
2016-06-30 $75
2016-03-31 $75
2015-12-31 $74
2015-09-30 $72
2015-06-30 $70
2015-03-31 $68
2014-12-31 $69
2014-09-30 $66
2014-06-30 $64
2014-03-31 $60
2013-12-31 $59
2013-09-30 $56
2013-06-30 $56
2013-03-31 $54
2012-12-31 $53
2012-09-30 $53
2012-06-30 $53
2012-03-31 $53
2011-12-31 $52
2011-09-30 $51
2011-06-30 $49
2011-03-31 $48
2010-12-31 $46
2010-09-30 $45
2010-06-30 $44
2010-03-31 $44
2009-12-31 $44
2009-09-30 $44
2009-06-30 $43
2009-03-31 $42
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.380B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00